Infectious Diseases Society of America guidance on the treatment of AmpC β-lactamase–producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii …
Abstract The Infectious Diseases Society of America (IDSA) is committed to providing up-to-
date guidance on the treatment of antimicrobial-resistant infections. A previous guidance …
date guidance on the treatment of antimicrobial-resistant infections. A previous guidance …
[HTML][HTML] Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
C Bartal, KVI Rolston, L Nesher - Infectious diseases and therapy, 2022 - Springer
Carbapenem-resistant Acinetobacter baumannii (CRAB) causes colonization and infection
predominantly in hospitalized patients. Distinction between the two is a challenge. When …
predominantly in hospitalized patients. Distinction between the two is a challenge. When …
Cefiderocol-compared to colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii
M Falcone, G Tiseo, A Leonildi… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
Cefiderocol may represent a therapeutic option for carbapenem-resistant Acinetobacter
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
baumannii (CRAB) infections, but clinical data are limited. This is an observational …
Colistin monotherapy versus combination therapy for carbapenem-resistant organisms
Background Pneumonia and bloodstream infections (BSI) due to extensively drug-resistant
(XDR) Acinetobacter baumannii, XDR Pseudomonas aeruginosa, and carbapenem …
(XDR) Acinetobacter baumannii, XDR Pseudomonas aeruginosa, and carbapenem …
[HTML][HTML] European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram …
Scope These ESCMID guidelines address the targeted antibiotic treatment of third-
generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem …
generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem …
[HTML][HTML] Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases …
G Tiseo, G Brigante, DR Giacobbe, AE Maraolo… - International Journal of …, 2022 - Elsevier
Management of patients with infections caused by multidrug-resistant organisms is
challenging and requires a multidisciplinary approach to achieve successful clinical …
challenging and requires a multidisciplinary approach to achieve successful clinical …
[HTML][HTML] Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort
EVK Ledger, A Sabnis, AM Edwards - Microbiology, 2022 - microbiologyresearch.org
The polymyxin and lipopeptide classes of antibiotics are membrane-targeting drugs of last
resort used to treat infections caused by multi-drug-resistant pathogens. Despite similar …
resort used to treat infections caused by multi-drug-resistant pathogens. Despite similar …
[HTML][HTML] Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms
CL Sy, PY Chen, CW Cheng, LJ Huang… - Journal of Microbiology …, 2022 - Elsevier
Antimicrobial drug resistance is one of the major threats to global health. It has made
common infections increasingly difficult or impossible to treat, and leads to higher medical …
common infections increasingly difficult or impossible to treat, and leads to higher medical …
[HTML][HTML] The role of colistin in the era of new β-lactam/β-lactamase inhibitor combinations
With the current crisis related to the emergence of carbapenem-resistant Gram-negative
bacteria (CR-GNB), classical treatment approaches with so-called “old-fashion antibiotics” …
bacteria (CR-GNB), classical treatment approaches with so-called “old-fashion antibiotics” …
Treatment of Acinetobacter baumannii severe infections
R Reina, C León-Moya, J Garnacho-Montero - Medicina Intensiva (English …, 2022 - Elsevier
Acinetobacter baumannii is a Gram-negative, multidrug-resistant (MDR) pathogen that
causes nosocomial infections, especially in intensive care units (ICUs) and …
causes nosocomial infections, especially in intensive care units (ICUs) and …